Clinical Trials Study
Copyright ©The Author(s) 2018.
World J Clin Cases. Dec 6, 2018; 6(15): 936-943
Published online Dec 6, 2018. doi: 10.12998/wjcc.v6.i15.936
Table 1 General clinical data between the two groups of patients
GroupCaseAge (yr)Gender
Maximum diameter of nodule (mm)
MaleFemale
Surgery group4646.2 ± 11.516308.13 ± 1.22
Microwave4145.8 ± 10.212298.87 ± 1.01
Ablation group
t2-value0.1710.302-3.061
P-value0.8650.5830.003
Table 2 Clinical indicators between the two groups (mean ± SD)
GroupCaseLength of hospital stay (d)Blood loss volume (mL)Surgical time (min)
Surgery group464.18 ± 0.5533.12 ± 5.0778.81 ± 12.19
Microwave411.77 ± 0.7110.32 ± 1.6525.02 ± 4.14
Ablation group
t-value17.83227.51126.892
P-value000
Table 3 Comparison of postoperative serum markers (mean ± SD)
GroupCaseCRP (mg/L)IL-6 (ng/L)TNF-α (ng/L)
Surgery group4612.05 ± 2.5714.44 ± 4.6151.39 ± 2.86
Microwave410.71 ± 0.394.02 ± 1.7843.55 ± 5.03
Ablation group
t-value27.95113.5919.059
P-value000
Table 4 Free triiodothyronine levels between the two groups before, 7 d after, and 30 d after treatment
FT3 (pmol/L)Preoperative7 d after surgery30 d after surgery
Microwave ablation group4.28 ± 0.494.25 ± 0.454.22 ± 0.53
Surgery group4.33 ± 0.783.09 ± 0.642.78 ± 0.84
Table 5 Comparison of free thyroxin levels before, 7 d after, and 30 d after treatment
FT4 (pmol/L)Preoperative7 d after surgery30 d after surgery
Microwave ablation group12.33 ± 1.5112.87 ± 2.6612.67 ± 2.83
Surgery group12.72 ± 1.6810.77 ± 2.259.45 ± 2.07
Table 6 Thyroid stimulating hormone levels between the two groups before, 7 d after, and 30 d after treatment
TSH (mIU/L)Preoperative7 d after surgery30 d after surgery
Microwave ablation group2.11 ± 1.471.42 ± 0.911.08 ± 1.35
Surgery group2.09 ± 1.0113.44 ± 2.3718.43 ± 2.67
Table 7 Postoperative complications in patients
GroupMicrowave ablation group (n = 41)Surgery group (n = 46)χ2P
Pharyngeal discomfort011.5080.219
Hoarseness12
Pain01
parathyroid injury00
Incision infection01
Cough after drinking water12
Incidence of complications4.9%15.2%